Skip to content

Study · Not a test of the peptide alone · 1996

1 result

[The search for ways to improve the efficacy of tuberculosis revaccination in children with immunological deficiency].

Chernushenko EF, Kadan LP, Kruglova IF, Podgainaia EA

Problemy tuberkuleza1 Jan 1996

PMID8907482 (opens in a new tab)PepBankPUB-08907482
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In animals with T-cell and macrophage immunodeficiency, immune response studies supported the feasibility of improving antituberculous vaccination with thymalin and sodium nucleinate.

    In plain wordsIn animals with immune deficiency, immune response studies supported the feasibility of improving tuberculosis vaccination with thymalin and sodium nucleinate.

    Peptide
    Thymalin
    Outcome
    Direction not reportedAntituberculous vaccination efficacy
    Study

    n: not reported in source

    T-cell and macrophage immunodeficiency
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The study of immune response to BCG in animals with T-cell and macrophage immunodeficiency validated feasibility of improving antituberculous vaccination efficacy by using thymalin and sodium nucleinate.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.